Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating
LU0415392835
Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating/ LU0415392835 /
NAV 03.10.2024
Diff.-3,3900
Ertragstyp
Ausrichtung
Fondsgesellschaft
448,9400 CHF
-0,75%
thesaurierend
Aktien
Waystone M.Co.(Lux) ▶
Zeitraum: 6 Monate 1 Jahr 2 Jahre 3 Jahre 5 Jahre
Anzahl an Fonds: 10 20 50
Titel
ISIN
Performance
Volatilität
Sharpe Ratio
1.
J.Henderson H.BioTech.F.IU2
LU1897414568
+42,40%
22,40%
1,75
2.
J.Henderson H.BioTech.F.H2
LU1897414485
+42,16%
22,38%
1,74
3.
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse I (acc) USD
LU0195948822
+37,92%
20,08%
1,73
4.
F.Biotechnology Dis.Fd.W USD
LU0976566496
+37,88%
20,11%
1,72
5.
J.Henderson H.BioTech.F.A2
LU1897414303
+41,59%
22,41%
1,71
6.
F.Biotechnology Dis.Fd.Z USD
LU1446800499
+37,43%
20,06%
1,70
7.
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse A (acc) USD
LU0109394709
+36,74%
20,09%
1,67
8.
Janus Henderson Horizon Biotechnology Fund H2 HEUR
LU2441283277
+39,99%
22,48%
1,63
9.
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse C (acc) USD
LU0260873095
+35,99%
20,08%
1,63
10.
Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse N (acc) USD
LU0122613499
+35,72%
20,10%
1,62
...
84.
Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating
LU0415392835
+4,71%
12,48%
0,12